Provided by Tiger Trade Technology Pte. Ltd.

Septerna, Inc.

37.86
-0.2900-0.76%
Volume:38.99K
Turnover:1.47M
Market Cap:1.77B
PE:-69.80
High:38.18
Open:38.15
Low:37.24
Close:38.15
52wk High:51.10
52wk Low:11.98
Shares:46.68M
Float Shares:22.90M
Volume Ratio:0.73
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5424
EPS(LYR):-1.1044
ROE:-6.34%
ROA:-7.13%
PB:4.57
PE(LYR):-34.28

Loading ...

Septerna CEO presents at Bank of America Securities Health Care Conference

Reuters
·
May 05

Septerna announces annual shareholder meeting

Reuters
·
May 01

Septerna initiated with a Buy at Stifel

TIPRANKS
·
May 01

Is Septerna (SEPN) Quietly Redefining Its GPCR Strategy With This First-in-Human SEP-479 Trial?

Simply Wall St.
·
Apr 22

Analysts Offer Insights on Technology Companies: Vicor (VICR), Ceragon Networks (CRNT) and Septerna, Inc. (SEPN)

TIPRANKS
·
Apr 20

Septerna President, COO Elizabeth Bhatt disposes 4,000 shares for $88,198.44

Reuters
·
Apr 18

Septerna Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 14

Septerna: Advancing GPCR Pipeline and Strategic Partnerships Support Buy Rating and $40 Price Target

TIPRANKS
·
Apr 14

Is Septerna (SEPN) Using Its First PTH1R Trial To Redefine Its GPCR Strategy?

Simply Wall St.
·
Apr 13

Septerna starts Phase 1 trial of SEP-479 oral hypoparathyroidism drug

Reuters
·
Apr 13

Septerna Inc - Phase 1 Trial Expected to Enroll up to 150 Participants

THOMSON REUTERS
·
Apr 13

Septerna Inc - Phase 1 Trial Data Expected in Late 2026 or Early 2027

THOMSON REUTERS
·
Apr 13

Septerna Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 25

Should Septerna’s New ATM and Shelf Offering Strategy Require Action From Septerna (SEPN) Investors?

Simply Wall St.
·
Mar 23

Septerna (SEPN) Is Down 13.5% After Launching US$150 Million ATM Equity Program and Filing Shelves

Simply Wall St.
·
Mar 16

Stock Track | Septerna Plummets 5.05% Intraday as Q4 Losses Reinforce Profitability Concerns

Stock Track
·
Mar 12

Septerna (SEPN) Q4 Loss Despite Revenue Surge Reinforces Bearish Profitability Narrative

Simply Wall St.
·
Mar 11

Septerna Is Maintained at Buy by Truist Securities

Dow Jones
·
Mar 11

Septerna price target raised to $35 from $34 at Truist

TIPRANKS
·
Mar 11

Truist Lifts Price Target on Septerna to $35 From $34, Keeps Buy Rating

MT Newswires Live
·
Mar 11